TransMedics Group, Inc. 8-K Report: Key Updates for January 2025

Based on the provided XML snippet from the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: TransMedics Group, Inc.
• CIK (Central Index Key): 0001756262
• State of Incorporation: Massachusetts (MA)
• SEC File Number: 001-38891
• EIN (Employer Identification Number): 83-2181531
• Address: 200 Minuteman Road, Andover, MA 01810
• Contact Number: (978) 552-0900

2. Filing Type:

• Form Type: 8-K (Current Report)

3. Filing Date:

• Date of Filing: January 8, 2025

4. Security Information:

• Common Stock: No par value per share
• Ticker Symbol: TMDX
• Exchange: NASDAQ

5. Period Information:

• The report pertains to a specific context with a start and end date of January 8, 2025.

Summary:

This filing represents an 8-K report by TransMedics Group, Inc., submitted to the SEC on January 8, 2025. The company is publicly traded on NASDAQ under the ticker symbol TMDX and has its headquarters in Andover, Massachusetts. The report likely contains significant updates or events affecting the company, as 8-K filings are typically used to disclose major events that shareholders should be aware of.

For further analysis, it would be beneficial to review the specific contents of the 8-K filing to understand the nature of the disclosed event(s).